In this interview we discuss the latest clinical news in urothelial carcinoma, what we’ve learned about the biology of these tumors, and how treatment of this disease has evolved.
Matthew I. Milowsky, MD
Advertisement
Articles by Matthew I. Milowsky, MD
Current efforts utilizing genomic strategies to unravel the biology of urothelial carcinoma will undoubtedly lead to rational targets, new therapies, and a renewed enthusiasm among researchers and clinicians working in this field-which ultimately will improve the lives of patients with this devastating disease.
Advertisement
Latest Updated Articles
- Advanced Urothelial Carcinoma: Moving the Field Forward
Published: March 16th 2013 | Updated:
Latest Progress in Treating Urothelial CarcinomaPublished: February 16th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
2
Response Rates Show Promise in Phase 1 Trial Involving ASCT in Metastatic PDAC
3
Case 2: Patient With High-Risk RRMM Relapsing After BCMA CAR T-Cell Therapy
4
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
5
